Edition:
United States

Korian SA (KORI.PA)

KORI.PA on Paris Stock Exchange

30.74EUR
16 Nov 2018
Change (% chg)

€-0.62 (-1.98%)
Prev Close
€31.36
Open
€31.50
Day's High
€31.88
Day's Low
€30.60
Volume
160,293
Avg. Vol
130,163
52-wk High
€35.28
52-wk Low
€22.84

Latest Key Developments (Source: Significant Developments)

Korian Places Tap Issue Of ODIRNANE For About 60 Million Euros
Tuesday, 18 Sep 2018 02:30am EDT 

Sept 18 (Reuters) - KORIAN SA ::SUCCESSFULLY PLACED A TAP ISSUE OF ODIRNANE FOR A NOMINAL AMOUNT OF APPROXIMATELY EUR 60 MILLION.ISSUE OF NEW BONDS AIMS AT REFINANCING NON-LISTED HYBRID BONDS ISSUED IN JUNE 2017.NEW BONDS SHALL BE ISSUED AT A PRICE OF EUR 40.90.SETTLEMENT AND DELIVERY DATE OF NEW BONDS IS EXPECTED TO TAKE PLACE ON SEPTEMBER 21(ST), 2018.  Full Article

Korian Launches Tap Issue Of ODIRNANE For A Nominal Amount Of About 60 Million Euros
Monday, 17 Sep 2018 11:35am EDT 

Sept 17 (Reuters) - KORIAN SA ::LAUNCHES A TAP ISSUE OF ODIRNANE FOR A NOMINAL AMOUNT OF APPROXIMATELY € 60 MILLION.BONDS WILL BE OFFERED AT A PRICE BETWEEN € 40.90 AND € 41.20 (INCLUDING ACCRUED INTERESTS WHICH ARE EQUAL TO € 0.22 PER BOND)..THE SETTLEMENT AND DELIVERY DATE OF THE NEW BONDS IS EXPECTED TO TAKE PLACE ON SEPTEMBER 21ST, 2018.FINAL PRICE IS EXPECTED TO BE DETERMINED TODAY ON SEPTEMBER 17TH, 2018..SETTLEMENT AND DELIVERY DATE OF THE NEW BONDS IS EXPECTED TO TAKE PLACE ON SEPTEMBER 21ST, 2018..BONDS TO BE FULLY ASSIMILATED TO ITS APPROXIMATELY € 240 MILLION ODIRNANE ISSUED IN JULY 2017.NEW BONDS ARE TO BE ISSUED ON THE SAME TERMS (EXCEPT ISSUE PRICE) AS THE ABOUT € 240 MILLION BONDS ISSUED IN JULY.  Full Article

Pharmagest Interactive Announces Partnership With Korian Group
Wednesday, 12 Sep 2018 12:11pm EDT 

Sept 12 (Reuters) - PHARMAGEST INTERACTIVE SA ::ANNOUNCES PARTNERSHIP WITH KORIAN GROUP.PARTNERSHIP AINS TO CO-CREATE AN INNOVATIVE MULTI-SERVICE OFFER FOR VULNERABLE PEOPLE AT HOME AND IN NURSING HOMES.  Full Article

Korian To Submit To Annual General Meeting Dividend Payment Of EUR 0.60 Per Share In Respect Of FY 2017
Thursday, 26 Apr 2018 01:45am EDT 

April 26 (Reuters) - Korian SA ::DECIDED TO SUBMIT TO ANNUAL GENERAL MEETING DIVIDEND OF EUR 0.60 PER SHARE IN RESPECT OF 2017 FINANCIAL YEAR..  Full Article

Korian FY Net Profit Group Share Up At ‍​163 Million Euros
Wednesday, 14 Mar 2018 12:46pm EDT 

March 14 (Reuters) - KORIAN ::FY EBITDA MARGIN OF 14.0%, UP 30 BASIS POINTS COMPARED WITH 2016 UNDERLYING MARGIN‍​.FY NET PROFIT GROUP SHARE EUR ‍​163 MILLION VERSUS EUR 131 MILLION YEAR AGO.FY EBITDA EUR 440‍​ MILLION VERSUS EUR 422 MILLION YEAR AGO.WILL PROPOSE A STABLE DIVIDEND OF €0.60 PER SHARE.IN 2018, KORIAN IS TARGETING REVENUE GROWTH OF AT LEAST 5.5%..REVISES ITS OBJECTIVES FOR OPERATING MARGIN (EBITDA) UPWARDS TO 14.3% IN 2019 AND CLOSE TO 15% IN 2021.CONFIRMS ALL OTHER FINANCIAL OBJECTIVES OF THE KORIAN 2020 STRATEGIC PLAN.IN 2018 MARGINS ARE EXPECTED TO INCREASE IN THE INTERNATIONAL SECTOR, PARTICULARLY IN GERMANY.IN 2018 THE GROUP EXPECTS ITS PORTFOLIO TO INCREASE BY OVER 2,500 BEDS IN TOTAL.IN 2018 IN TOTAL, KORIAN EXPECTS A LIMITED DECLINE IN EBITDA MARGIN COMPARED WITH 2017.  Full Article

Korian Says Is Not In Any Discussion Regarding Possible Sale
Tuesday, 6 Mar 2018 02:08am EST 

March 6 (Reuters) - KORIAN ::SAYS IS CURRENTLY NOT IN DISCUSSION WITH ANY INVESTMENT FUND REGARDING A POSSIBLE ACQUISITION OF OUR COMPANY‍​.  Full Article

Korian FY Revenue Up at 3.14 Billion Euros
Wednesday, 7 Feb 2018 11:53am EST 

Feb 7 (Reuters) - KORIAN ::FY REVENUE EUR 3.14 BILLION VERSUS EUR 2.99 BILLION YEAR AGO.IN 2018, KORIAN IS TARGETING REVENUE GROWTH OF AT LEAST 5.5%‍​.CONFIRMATION OF THE FINANCIAL OBJECTIVES OF THE KORIAN 2020 PLAN.IN TOTAL, THE GROUP EXPECTS ITS PORTFOLIO TO INCREASE BY OVER 2,500 BEDS‍​.EXPECTS ITS OPERATING INCOME (EBITDA) TO INCREASE LESS THAN REVENUE.  Full Article

Korian Q3 revenue up at 791 million euros
Tuesday, 24 Oct 2017 11:41am EDT 

Oct 24 (Reuters) - KORIAN SA ::Q3 REVENUE EUR 791 ‍MILLION VERSUS EUR 754 MILLION YEAR AGO.KORIAN: REVENUE UP 5% IN THE THIRD QUARTER OF 2017.‍CONFIRMS ITS OBJECTIVES FOR 2017 OF REVENUE GROWTH OVER 5%​.‍CONFIRMS OBJECTIVES FOR 2017 OF OPERATING MARGIN (EBITDA) OF AROUND 13.7%, EQUAL TO RESTATED MARGIN FOR 2016.​.  Full Article

Korian H1 net profit group share rises to 38 million euros
Wednesday, 13 Sep 2017 12:32pm EDT 

Sept 13 (Reuters) - KORIAN ::H1 REVENUE UP 4.9%, AT EUR 1.54 BLN‍​.H1 EBITDA EUR 209 MILLION VERSUS EUR 206.7 MILLION YEAR AGO.ANNUAL REVENUE GROWTH AND OPERATING MARGIN OBJECTIVES CONFIRMED‍​.H1 NET PROFIT GROUP SHARE EUR 38 MILLION VERSUS EUR 32 MILLION YEAR AGO.AT 30 JUNE 2017, NET FINANCIAL DEBT TOTALLED €2,317 MILLION, WHICH IS STABLE COMPARED TO THE LEVEL AT 31 DEC. 2016.  Full Article

Icade announces that Korian Group, Icade Santé and Icade Promotion signed a development partnership
Wednesday, 13 Sep 2017 01:07am EDT 

Sept 13 (Reuters) - ICADE SA ::KORIAN GROUP, ICADE SANTÉ AND ICADE PROMOTION SIGNED A DEVELOPMENT PARTNERSHIP.AGRREMENT INVOLVES A FIRST BATCH OF 15 NEW BUILDINGS TO BE DELIVERED BY 2020 IN FRANCE‍​.DEVELOPER ICADE PROMOTION WILL DEVELOP, DESIGN AND BUILD THE FACILITIES UNDER CONTRACT..BEFORE DELIVERY, KORIAN MAY EXERCISE A PURCHASE OPTION FOR EACH PROPERTY.ICADE SANTÉ IS ENTITLED TO ACQUIRE SOME OF THESE PROPERTIES PURSUANT TO OFF PLAN LEASE AGREEMENTS (BEFA)..  Full Article

Germany's Bonitas and Median to join run of health services deals -sources

FRANKFURT, Nov 8 Germany's fragmented healthcare services sector is poised to continue its recent consolidation with imminent sales of Bonitas Holding and Median Kliniken, sources close to the matter said.